Anne Mauger de Varennes

Anne Mauger de Varennes

Auto-generated profile, based on publicly available information

Anne Mauger de Varennes

University of Rennes, Department of Urology, CHU de Rennes, Rennes, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Progrès en Urologie
Verified
Journal Article
Closed access
NBN. Ali Benali
N. Ali Benali
Benjamin PradereBenjamin Pradere
Benjamin Pradere
FLF. Lannes
F. Lannes
VDV. Thi Dang
V. Thi Dang
AVA. Mauger de Varennes
A. Mauger de Varennes
XMX. Matillon
X. Matillon

1 November 2020 in Progrès en Urologie
Verified
Journal Article
Closed access
VDV. Dang
V. Dang
FLF. Lannes
F. Lannes
FBF. Bardet
F. Bardet
MCM. Chabenes
M. Chabenes
IDI. Dominique
I. Dominique
ZKZine-Eddine Khene
Zine-Eddine Khene

15 April 2025 in The French Journal of Urology
Verified
Journal Article
Open access
AVAnne Mauger de Varennes
Anne Mauger de Varennes
MMMarie Mermier
Marie Mermier
ZKZine Eddine Khene
Zine Eddine Khene
AGAnis Gasmi
Anis Gasmi
ECEtienne Courboin
Etienne Courboin
GVGrégory Verhoest
Grégory Verhoest
Radical cystectomy is the gold standard technique for muscle-invasive bladder cancer and resistant non muscle-invasive bladder cancer. This surgery presents a high rate of complications despite the advance of robotic surgery. The aim of this study is to compare the complications according to the presence of ureteral stents or not. Two hundred consecutive patients who underwent robotic radical cystectomy for bladder cancer at our center between 2012 and 2022 were included in this retrospective study. Cessation of upper tract drainage was introduced prospectively in February 2021, without any selection bias. Patients were divided into 2 groups: ureteral stents (US) or no ureteral stents (NUS). All complications were analyzed during 3 postoperative months. Urinary diversion-specific complications were analyzed during 12 postoperative months. Over the 200 included patients, 58 did not have any ureteral stents (29%). The overall postoperative complication rate was nearly identical between the NUS group at 48% and the US group at 53% (P=0.56). The rate of severe complications≥Clavien3a seemed lower in the NUS group at 15% versus 24% in the US group (Chi2: 1.73, P=0.19), as were the rates of infectious complications: NUS 29% versus US 38% (Chi2: 1.20, P=0.27). These results were the same in subgroup analyses. Complications on the urinary diversion at 12 months were 12% for the NUS group and 20% for the US group (Chi2: 1.67, P=0.196). Going against all dogmas, the absence of upper urinary tract drainage for cystectomy does not increase the risk of early and late complications, and even seems to limit infectious and late complications such as stenosis.

1 November 2020 in Progrès en Urologie
Verified
Journal Article
Closed access
AVA. Mauger de Varennes
A. Mauger de Varennes
ZKZine-Eddine Khene
Zine-Eddine Khene
Benjamin PradereBenjamin Pradere
Benjamin Pradere
FLF. Lannes
F. Lannes
LFLucas Freton
Lucas Freton
CPC. Plassais
C. Plassais

1 June 2021 in European Urology
Verified
Journal Article
Closed access
EME. Seizilles de Mazancourt
E. Seizilles de Mazancourt
XMX.M Matillon
X.M Matillon
UPUgo Pinar
Ugo Pinar
IDIgor Duquesne
Igor Duquesne
CPC. Plassais
C. Plassais
Benjamin PradereBenjamin Pradere
Benjamin Pradere

1 June 2021 in European Urology
Verified
Journal Article
Closed access
WBW. Berchiche
W. Berchiche
MSM. Sbizzera
M. Sbizzera
FLF. Lannes
F. Lannes
UPUgo Pinar
Ugo Pinar
IDIgor Duquesne
Igor Duquesne
Benjamin PradereBenjamin Pradere
Benjamin Pradere